INT218499

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.00
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.74
Pain Relevance 0.13

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell proliferation (Cfb) peptidase activity (Cfb) extracellular space (Cfb)
extracellular region (Cfb)
Cfb (Mus musculus)
ap (Mus musculus)
Pain Link Frequency Relevance Heat
rheumatoid arthritis 6 87.80 High High
ischemia 3 84.12 Quite High
Inflammation 10 5.00 Very Low Very Low Very Low
Inflammatory response 2 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
psoriasis 1 5.00 Very Low Very Low Very Low
Multiple sclerosis 1 5.00 Very Low Very Low Very Low
cva 1 5.00 Very Low Very Low Very Low
antagonist 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Rheumatoid Arthritis 6 87.80 High High
Asthma 3 86.64 High High
Systemic Lupus Erythematosus 6 86.28 High High
Reperfusion Injury 2 84.88 Quite High
Cv Unclassified Under Development 3 84.12 Quite High
Disease 15 83.44 Quite High
Sprains And Strains 1 53.44 Quite High
Salivary Gland Disease 22 28.48 Quite Low
Targeted Disruption 2 15.84 Low Low
Hemolysis 19 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Selective inhibition of the AP by properdin inhibitors such as IxACs may therefore be used to treat pathological effects of uncontrolled complement activation by this pathway, without compromising the classical and lectin pathways.


properdin Negative_regulation (inhibition) of AP
1) Confidence 0.00 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2151134 Disease Relevance 0.74 Pain Relevance 0.13

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox